Review of renal carcinoma with t(6;11)(p21;q12) with focus on clinical and pathobiological aspects.
暂无分享,去创建一个
Y. Nagashima | N. Sasaki | G. Martignoni | O. Hes | A. Tanaka | F. Petersson | M. Michal | K. Matsuura | M. Moriyama | Keiji Inoue | N. Kuroda | A. Ishihara | Azusa Tanaka
[1] Y. Chen,et al. [Renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with lymph node metastasis diagnosed after an injury accident: report of a case]. , 2014, Zhonghua bing li xue za zhi = Chinese journal of pathology.
[2] P. Sathe,et al. Xp11 translocation renal cell carcinoma. , 2013, Indian journal of pathology & microbiology.
[3] M. Ladanyi,et al. Molecular Confirmation of t(6;11)(p21;q12) Renal Cell Carcinoma in Archival Paraffin-embedded Material Using a Break-apart TFEB FISH Assay Expands its Clinicopathologic Spectrum , 2012, The American journal of surgical pathology.
[4] W. Linehan,et al. Translocation Renal Cell Carcinomas in Adults: A Single-institution Experience , 2012, The American journal of surgical pathology.
[5] Ximing J. Yang,et al. A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases. , 2012, Human pathology.
[6] C. Pan,et al. Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect. , 2012, Histology and histopathology.
[7] Y. Ishikawa,et al. Diverse Fusion Patterns and Heterogeneous Clinicopathologic Features of Renal Cell Carcinoma With t(6;11) Translocation , 2012, The American journal of surgical pathology.
[8] N. Kuroda,et al. Renal carcinoma with (6;11)(p21;q12) translocation: Report of an adult case , 2011, Pathology international.
[9] F. Izquierdo-García,et al. Renal Translocation Carcinoma With Expression of TFEB , 2011, International journal of surgical pathology.
[10] Xiong-zeng Zhu,et al. Renal cell carcinoma with t(6;11) translocation: a patient case with a novel Alpha-TFEB fusion point. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] A. Parwani,et al. Xp11.2 translocation renal cell carcinoma. , 2010, Archives of pathology & laboratory medicine.
[12] C. Pan,et al. Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas , 2009, Modern Pathology.
[13] Karl J. Dykema,et al. Renal Translocation Carcinomas: Clinicopathologic, Immunohistochemical, and Gene Expression Profiling Analysis of 31 Cases With a Review of the Literature , 2008, The American journal of surgical pathology.
[14] L. Vreede,et al. Molecular mechanisms underlying the MiT translocation subgroup of renal cell carcinomas , 2007, Cytogenetic and Genome Research.
[15] M. Ladanyi,et al. Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum , 2007, The American journal of surgical pathology.
[16] L. Pecciarini,et al. Characterization of t(6;11)(p21;q12) in a renal‐cell carcinoma of an adult patient , 2007, Genes, Chromosomes and Cancer.
[17] M. Ladanyi,et al. The evolving story of renal translocation carcinomas. , 2006, American journal of clinical pathology.
[18] M. Ladanyi,et al. Translocation carcinomas of the kidney after chemotherapy in childhood. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] M. Ladanyi,et al. Translocation carcinomas of the kidney. , 2005, Clinics in laboratory medicine.
[20] M. Ladanyi,et al. Renal Carcinomas With the t(6;11)(p21;q12): Clinicopathologic Features and Demonstration of the Specific Alpha-TFEB Gene Fusion by Immunohistochemistry, RT-PCR, and DNA PCR , 2005, The American journal of surgical pathology.
[21] M. Mansukhani,et al. Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1. , 2004, Cancer genetics and cytogenetics.
[22] M. Ladanyi,et al. Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas. , 2003, Pathology.
[23] E. van den Berg,et al. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. , 2003, Human molecular genetics.
[24] T. Shuin,et al. Review of renal oncocytoma with focus on clinical and pathobiological aspects. , 2003, Histology and histopathology.
[25] M. Ladanyi,et al. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[26] H. Enzan,et al. Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. , 2003, Histology and histopathology.
[27] P. Argani,et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. , 2001, The American journal of pathology.
[28] E. Berg,et al. Two cases of renal cell carcinoma, clear cell type, revealing a t(6;11)(p21;q13) , 1996 .
[29] P. Argani,et al. Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney , 2012, Modern Pathology.
[30] O. Hes,et al. A distinctive translocation carcinoma of the kidney [“rosette-like forming,” t(6;11), HMB45-positive renal tumor] , 2008, International Urology and Nephrology.
[31] H. Enzan,et al. Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects. , 2003, Histology and histopathology.
[32] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .